100 results
Page 2 of 5
424B5
yob5t7vcz7
12 Nov 21
Prospectus supplement for primary offering
4:09pm
8-K
7601ec2mkj 3qx
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-1.1
th08kmcwyzcsqw84j
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
8-K
EX-99.1
8jvy fdifo
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm
424B5
2sfcdu
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
y1080h1gqogc htn
17 Mar 21
Prospectus supplement for primary offering
5:07pm
8-K
uocztlqlv47 panm3
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am